Retropubic, transobturator slings show long-term equivalence for SUI

By Joanna Lyford, Senior medwireNews Reporter

Two minimally invasive surgical procedures for female urinary incontinence offer similar long-term cure rates and high levels of patient satisfaction, follow-up of clinical trial participants has found.

The results, published in European Urology, indicate that retropubic and transobturator sling placement are similarly effective, achieving objective and subjective cure in more than 80% of women who undergo the procedure.

In 2004, Carl Nilsson (Helsinki University Central Hospital, Finland) and team initiated a randomised controlled trial in which they compared retropubic tension-free vaginal tape (TVT) with transobturator tension-free vaginal tape (TVT-O) for the treatment of stress urinary incontinence (SUI) in 268 women.

In all, 254 (94.9%) women returned to the clinic for a 5-year follow-up assessment.

At this point, the proportion of women considered to be objectively cured – ie, a negative stress test, a negative pad test and no retreatment for stress incontinence – was 84.7% in the TVT group and 86.2% in the TVT-O group.

These figures fell slightly, to 81.6% and 80.3%, respectively, when women lost to follow-up were classified as failures.

Subjective cure rates – defined as treatment that completely met the woman’s expectations – were similarly high, at 84.6% in the TVT group and 85.6% in the TVT-O group.

Furthermore, women in both groups showed a significant increase in their condition-specific quality-of-life scores at 5 years versus baseline.

There was a low incidence of de novo urgency incontinence after surgery, at 3.1% with TVT and 2.4% with TVT-O, and 4.7% of women reported experiencing moderate/severe frequency and urgency at 5 years.

However, complication rates associated with the procedure were low, with no difference between groups, and the tape material did not cause any adverse tissue reactions.

Nilsson and co-workers conclude: “The long-term follow-up results of the present randomized trial comparing the retropubic TVT procedure with the inside-out TVT-O procedure reveals no difference in cure rate or complication rate between the two operations.”

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Men with sneaky testosterone physiology have worse prostate cancer outcomes, study finds